Login / Signup

Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm.

Jonathan GolledgeClare ArnottJoseph MoxonHelen MonaghanRichard NormanDylan MorrisQiang LiGreg JonesJustin RoakeMatt BownBruce Neal
Published in: Trials (2021)
Australian Clinical Trials ACTRN12618001707257 . Registered on 16 October 2018.
Keyphrases
  • abdominal aortic aneurysm
  • clinical trial
  • study protocol
  • phase ii
  • phase iii
  • placebo controlled
  • open label
  • double blind
  • randomized controlled trial
  • risk factors
  • squamous cell carcinoma